Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease

• Hoofdauteurs: Debora Curci (Auteur), Marianna Lucafò (Auteur), Adriana Cifù (Auteur), Martina Fabris (Auteur), Matteo Bramuzzo (Auteur), Stefano Martelossi (Auteur), Raffaella Franca (Auteur), Giuliana Decorti (Auteur), Gabriele Stocco (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2021-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Infliximab is commonly used in inflammatory bowel disease (IBD), however, differences in clinical response among patients are common. Several studies have considered the possibility that these differences are caused by genetic variability even if no unique marker has been yet identified in...